Amgen Inc.

BUL:AM1 Voorraadrapport

Marktkapitalisatie: €153.7b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Amgen Toekomstige groei

Future criteriumcontroles 4/6

Amgen is forecast to grow earnings and revenue by 23.6% and 2.9% per annum respectively. EPS is expected to grow by 25.3% per annum. Return on equity is forecast to be 240.8% in 3 years.

Belangrijke informatie

23.6%

Groei van de winst

25.3%

Groei van de winst per aandeel

Biotechs winstgroei0%
Inkomstengroei2.9%
Toekomstig rendement op eigen vermogen240.8%
Dekking van analisten

Good

Laatst bijgewerkt08 Aug 2024

Recente toekomstige groei-updates

Recent updates

Winst- en omzetgroeiprognoses

BUL:AM1 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/202634,8917,00912,71513,59521
12/31/202534,2106,00212,43613,17726
12/31/202433,1843,49416,82415,16726
6/30/202430,9343,1305,4816,446N/A
3/31/202429,5323,7637,0988,096N/A
12/31/202328,1906,7177,3598,471N/A
9/30/202326,8337,5669,37910,582N/A
6/30/202326,5827,9799,68510,800N/A
3/31/202326,1907,9177,5318,621N/A
12/31/202226,3236,5528,7859,721N/A
9/30/202226,3306,8358,9979,880N/A
6/30/202226,3846,5768,3559,320N/A
3/31/202226,3165,7238,4179,321N/A
12/31/202125,9795,8938,3819,261N/A
9/30/202125,7675,6097,8408,606N/A
6/30/202125,4845,7468,8979,556N/A
3/31/202125,1647,0859,83510,467N/A
12/31/202025,4247,2649,88910,497N/A
9/30/202024,9877,35210,23510,858N/A
6/30/202024,3017,29910,20910,867N/A
3/31/202023,9667,6758,7959,439N/A
12/31/201923,3627,8428,5329,150N/A
9/30/201923,3958,0679,1759,830N/A
6/30/201923,5627,9589,0709,726N/A
3/31/201923,7508,0759,71510,414N/A
12/31/201823,7478,39410,55811,296N/A
9/30/201823,3192,20210,44811,114N/A
6/30/201823,1882,36410,64211,295N/A
3/31/201822,9392,219N/A11,519N/A
12/31/201722,8491,979N/A11,177N/A
9/30/201723,0128,178N/A11,265N/A
6/30/201723,0508,174N/A10,473N/A
3/31/201722,9287,893N/A10,824N/A
12/31/201622,9917,722N/A10,354N/A
9/30/201622,5627,587N/A9,327N/A
6/30/201622,4747,433N/A9,557N/A
3/31/201622,1567,216N/A10,164N/A
12/31/201521,6626,939N/A9,731N/A
9/30/201521,4576,433N/A10,103N/A
6/30/201520,7655,814N/A9,952N/A
3/31/201520,5755,708N/A8,895N/A
12/31/201420,0635,158N/A8,952N/A
9/30/201419,7434,885N/A7,945N/A
6/30/201419,4605,009N/A7,011N/A
3/31/201418,9594,720N/A6,384N/A
12/31/201318,6765,081N/A6,291N/A
9/30/201317,9804,848N/A5,268N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: AM1's forecast earnings growth (23.6% per year) is above the savings rate (3%).

Winst versus markt: AM1's earnings (23.6% per year) are forecast to grow faster than the BG market (13.5% per year).

Hoge groeiwinsten: AM1's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: AM1's revenue (2.9% per year) is forecast to grow slower than the BG market (24.5% per year).

Hoge groei-inkomsten: AM1's revenue (2.9% per year) is forecast to grow slower than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: AM1's Return on Equity is forecast to be very high in 3 years time (240.8%).

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y